Accel Wealth Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Accel Wealth Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$11,453
+153.7%
1,0450.0%0.01%
+150.0%
Q4 2022$4,514
-92.3%
1,045
-86.7%
0.00%
-93.8%
Q3 2022$59,000
+1080.0%
7,855
+1519.6%
0.03%
+966.7%
Q2 2022$5,000
-16.7%
4850.0%0.00%0.0%
Q1 2022$6,000
-45.5%
4850.0%0.00%
-40.0%
Q4 2021$11,000
+37.5%
485
+38.6%
0.01%0.0%
Q3 2021$8,000
-69.2%
350
-82.4%
0.01%
-70.6%
Q2 2021$26,000
+333.3%
1,985
+309.3%
0.02%
+240.0%
Q1 2021$6,000
-14.3%
4850.0%0.01%
-28.6%
Q4 2020$7,0004850.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders